Catherine Roche‐Lestienne

机构：Inserm, Université de Lille, Lille’s Cardiology Hospital, Hôpital Jeanne de Flandre, Institut Bergonié · ORCID：0000-0002-7998-3817

发表论文 156 篇 · 总被引 4597 次 · h-index 35

代表论文

• Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial (2020 · Clinical Cancer Research · 被引 146)
• NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis (2016 · Leukemia · 被引 136)
• Targeting MYC in multiple myeloma (2018 · Leukemia · 被引 132)
• TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia (2017 · Clinical Cancer Research · 被引 99)
• The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma (2016 · Leukemia · 被引 84)
• Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group (2018 · Cancer · 被引 75)